Aequitas Research - Genetron (泛生子) Pre-IPO - Expertise to be proven outside brain tumor: Genetron, a China-based precision oncology company, plans to raise up to USD 100 million to list in the US. Genetron was founded by Dr Yan, a… https://t.co/xAPmwS46jX #equity #stocks